Navigation Links
Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
Date:4/30/2008

OMAHA, Neb., April 30 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO), a global genetic analysis and services company, today announced the National Cancer Institute had approved a proposal to perform mutational analysis and sequencing of the mitochondrial genes in the NCI 60 cancer cell line panel.

Mitochondrial damage is increasingly recognized as an early warning signal in several different types of cancer. This is the first comprehensive evaluation of the mitochondrial genome in the NCI 60 panel. The data from this study will be a valuable tool for integrating mitochondrial genomics with other data derived from the NCI 60 panel.

"Tens of thousands of compounds have been tested against the NCI 60 cell lines in the NCI's pharmacological database of cancer drugs," chief scientific officer Dr. Eric Kaldjian described. "This collaboration makes it possible to test whether in vitro responses to anti-cancer agents are linked to alterations in the mitochondrial genome and can be detected with our sensitive mutation detection technology."

Chief executive officer Craig Tuttle remarked, "Over the last 2 years, we have grown our laboratory services business focusing on diseases associated with mitochondrial DNA. As we learn more about the mitochondria and its role in disease, we are finding that mitochondrial mutation testing can provide diagnostic insights earlier in the disease process giving physicians early warning signals they can use to monitor at risk patients or even begin therapy. This study is an important milestone for the company and will further validate our leadership in the analysis of the mitochondrial genome in disease. The NCI 60 panel study further demonstrates Transgenomic's expertise in the evolving area of diagnostic testing for mitochondrial mutations."

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services of automated high sensitiv
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
3. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
4. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
5. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
8. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
9. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... LONDON , December 19, 2014 ... authentication services in the World announced the appointment of ... Anthony R. Vonsée, as Chief Channels and Partner Officer. ... Datanomic since 2004 through to its acquisition by Oracle ... Development Director at Geneva and ...
(Date:12/19/2014)... -- You,re visiting the dentist for what you think ... she says you need a root canal. Though it,s ... several questions and feel apprehensive about your upcoming procedure. ... to worry about. The Pennsylvania Dental Association (PDA) wants ... the public may have surrounding this common procedure that ...
(Date:12/19/2014)... , Dec. 19, 2014 Breckenridge Pharmaceutical, ... multi-product agreement with MSN Laboratories Pvt. Ltd. ( ... expect to commercialize several new ANDAs.  Under the terms ... the products exclusively to Breckenridge for the U.S. market, ... its label.  Breckenridge and MSN have agreed to develop ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Root Canals Have Become More Routine 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2
... 2 Cornerstone Therapeutics Inc. (Nasdaq: ... specialty pharmaceutical company focused on acquiring, developing and commercializing ... today announced that the Company has entered into a ... Inc, also known as The Cough Company ("The Cough ...
... ,  Aug. 2 K-V Pharmaceutical Company (NYSE: ... New York Stock Exchange ("NYSE") on July 27, 2010 ...  The NYSE informed the Company that its Class A Common ... closing price of a NYSE security of not less than ...
Cached Medicine Technology:Cornerstone Therapeutics Announces Collaboration with The Cough Company 2Cornerstone Therapeutics Announces Collaboration with The Cough Company 3Cornerstone Therapeutics Announces Collaboration with The Cough Company 4K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 2K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 4K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 5K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 6K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 7K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 8K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 9
(Date:12/21/2014)... (PRWEB) December 21, 2014 AlignLife of ... in need while at the same time helping people get ... a non-profit community-based organization committed to serving those persons in ... their needs to improve the quality of life. Dr. Michael ... an impact in the local community and he knew he ...
(Date:12/21/2014)... Aliso Viejo, California (PRWEB) December 21, 2014 ... Film Studios have announced a new intro plugin for ... users to animate pictures, videos, logos, and more with ... Studios. “We’ve given our users the tools needed to ... Studios' ProMotion allows Final Cut Pro X users to ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is a professional ... . The business has recently shown its new engineered ... all its bamboo flooring models. , BambooIndustry.com’s customers come ... Asia and more. According to the CEO of the ... very fast in the past few years, and the ...
(Date:12/20/2014)... 20, 2014 Dress company LunaDress has recently ... announced its Christmas Sale, offering big discounts on all of ... has an idea to own a perfect wedding gown. If ... wedding dress, then come to LunaDress. Many different wedding dress ... Visit our website now and enjoy the current special offer, ...
(Date:12/20/2014)... 2014 The Doctor’s Office Urgent Care of ... part of a decade. They’ve treated over 40,000 patients ... healthcare alternative to the Paramus area. , ... additions to their staff of top-notch board certified physicians: Christine ... These new doctors will work tirelessly to carry ...
Breaking Medicine News(10 mins):Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2
... ... Texas. , ... 2010 -- Rosenheck and Co., Inc. is excited to announce our new website for 2010. ... products for Oklahoma and Texas . Thousands of seniors depend ...
... would block hormone that controls uterine contractions , ... shows promise in treating severe menstrual cramps, researchers say. ... 90 percent of women of child-bearing age and is ... women in their teens and 20s, according to a ...
... for early halt, expert says , TUESDAY, March 23 ... in clinical trials that are stopped early due to ... a comparison of 91 truncated trials with 424 comparable ... early -- in particular, smaller studies -- reported exaggerated ...
... March 23 A national poll released recently by Rasmussen Reports shows that 56 percent of Americans oppose a tax on soft drinks, strongly believing that ... ... ... ...
... , , ... ... ... ...
... agent that targets metastatic breast cancer to find if it ... cancer patients, whose disease has spread despite treatment, could be ... determine the efficacy of an investigational agent used to target ... one of the things we can offer patients is our ...
Cached Medicine News:Health News:Rosenheck and Co. Launches New Website Outlining Medicare Supplement Services for Oklahoma and Texas 2Health News:Menstrual Cramps May Be Helped by New Drug 2Health News:Abbreviated Trials Yield Misleading Results: Study 2Health News:National Poll Finds Americans Oppose Tax on Soft Drinks; Don't Believe it Will Go to Improve Public Health 2Health News:National Poll Finds Americans Oppose Tax on Soft Drinks; Don't Believe it Will Go to Improve Public Health 3Health News:National Poll Finds Americans Oppose Tax on Soft Drinks; Don't Believe it Will Go to Improve Public Health 4Health News:Bishops Encourage Vigilance that Health Care Legislation Protects Conscience, Does Not Fund Abortion 2Health News:Bishops Encourage Vigilance that Health Care Legislation Protects Conscience, Does Not Fund Abortion 3Health News:Bishops Encourage Vigilance that Health Care Legislation Protects Conscience, Does Not Fund Abortion 4Health News:Bishops Encourage Vigilance that Health Care Legislation Protects Conscience, Does Not Fund Abortion 5Health News:Bishops Encourage Vigilance that Health Care Legislation Protects Conscience, Does Not Fund Abortion 6
... to detect sequences of the following ... 2 and 3; influenza virus A ... A and B. Laboratories may ... tests., *Analyte Specific Reagents. ...
... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
... NGEN-brand ASRs* are specifically designed for ... with two-color fluorescence detection systems. The ... the detection of mutations associated with ... as well as reagents for the ...
... offers reagents for the detection of ... the G1691A mutation on the Factor ... mutation on the Prothrombin gene. Laboratories ... homebrew tests.,, *Analyte Specific ...
Medicine Products: